What is the recommended diagnostic approach for bullous pemphigoid?

Diagnosis of Bullous Pemphigoid

The diagnosis of bullous pemphigoid requires direct immunofluorescence (DIF) showing linear IgG and/or C3 deposits at the dermoepidermal junction, combined with compatible clinical features and histopathology; DIF is the most critical and essential test for diagnosis. 1

Clinical Evaluation

Key Historical Features to Obtain

• Age: Patients typically >70 years old
• Drug history: Specifically ask about diuretics (especially loop diuretics, spironolactone) and psycholeptic drugs (phenothiazines) taken within the past 1-6 months
• Neurological comorbidities: Screen for dementia, Parkinson's disease, or cerebrovascular disease
• Symptom timeline: Document when pruritus and lesions first appeared 1

Physical Examination Findings

Classical presentation:

• Severely pruritic bullous eruption
• Symmetric distribution on flexural surfaces of limbs, inner thighs, abdomen, and trunk
• Bullae arising from erythematous inflamed skin
• Absence of atrophic scarring
• Absence of predominant neck/head involvement
• Rare mucosal involvement
• Negative Nikolsky sign 1

Atypical presentations (may delay diagnosis):

• Excoriated lesions only
• Prurigo nodularis-like lesions
• Eczematous or urticarial plaques
• Localized bullae
• Dyshidrosiform (acral) lesions 1

Diagnostic Algorithm

Step 1: Skin Biopsies (Two Separate Specimens Required)

For histopathology:

• Take from an early intact bulla arising on erythematous skin
• Place in formalin
• Expected findings: Subepidermal bullae with eosinophils and/or neutrophils, dermal infiltrate of eosinophils/neutrophils, or eosinophil marginalization along the dermoepidermal junction 1

For direct immunofluorescence (DIF):

• Take from perilesional skin (avoid blistered skin)
• Transport in cryotube with liquid nitrogen, Michel's fixative, or 0.9% NaCl solution
• This is the most critical diagnostic test 1
• Expected findings: Linear deposits of IgG and/or C3 along the dermoepidermal junction (occasionally IgA and IgE) 1

Critical pitfall: DIF positivity is essential for BP diagnosis—without it, the diagnosis cannot be confirmed 1. Recent research confirms DIF has the highest sensitivity (95.8%) and specificity (100%) among all diagnostic tests 2.

Step 2: Serological Testing (Choose One Approach)

After confirming positive DIF, proper classification requires detecting circulating autoantibodies using one of these methods:

Option A: ELISA (Preferred for specificity)

• Anti-BP180 (NC16A domain) IgG antibodies
• If negative, test for anti-BP230 IgG antibodies
• Sensitivity: 75.2%, Specificity: 93.5%
• A cut-off of ≥10 IU/mL provides 100% specificity 2
• Combined DIF + ELISA achieves 99.8% sensitivity and 100% specificity 2

Option B: Indirect Immunofluorescence (IIF)

• Use 1 mol/L NaCl-separated normal human skin substrate
• Look for IgG binding to the epidermal side of split skin (sometimes both epidermal and dermal)
• Detects antibodies in up to 80% of cases
• Sensitivity: 78.3%, Specificity: 98.1% 1, 2

Step 3: Clinical Criteria Validation

When three of four clinical characteristics are present in a patient with positive DIF (linear IgG/C3 at dermoepidermal junction), BP diagnosis can be made with high confidence:

1. Age >70 years
2. Absence of atrophic scars
3. Absence of mucosal involvement
4. Absence of predominant bullous lesions on neck and head 1

Special Diagnostic Scenarios

When DIF is negative but clinical suspicion is high:

• Consider immunohistochemistry for C3d and C4d on the same formalin-fixed tissue used for routine histopathology
• This can detect linear deposits along the basement membrane zone in cases where DIF specimen was suboptimal 3
• IHC sensitivity (80.8%) is similar to DIF but may salvage cases with negative or inadequate DIF results 3

For differentiating BP from other subepidermal blistering diseases:

• Perform DIF on NaCl-split skin to determine whether IgG deposits are on the epidermal side (BP) versus dermal side (epidermolysis bullosa acquisita)
• Analyze n-serration pattern of DIF deposits 1

Common Diagnostic Pitfalls

1. Obtaining DIF from blistered rather than perilesional skin reduces diagnostic yield
2. Improper specimen transport (e.g., placing DIF specimen in formalin instead of appropriate medium) renders the test useless
3. Diagnosing BP without positive DIF—this violates the essential diagnostic criteria 1
4. Missing non-bullous BP variants that present only with pruritus, excoriations, or urticarial lesions for weeks to months before bullae appear 4, 5
5. Failing to obtain drug history for the preceding 1-6 months, missing potential triggers

The diagnostic approach is algorithmic: obtain both biopsies simultaneously, confirm with DIF (mandatory), add serological testing for classification, and validate with clinical criteria. This structured approach achieves near-perfect diagnostic accuracy when properly executed 2.